BioMarin Pharmaceutical Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2020
Total Assets: $5.85B
Liabilities Breakdown FY2020
Total Liabilities: $1.74B
Asset Breakdown
Total Assets: $5.85B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $649.2M | 11.1% |
| Accounts Receivable | $448.4M | 7.7% |
| Inventory | $698.5M | 11.9% |
| Property, Plant & Equipment | $1.03B | 17.7% |
| Goodwill | $196.2M | 3.4% |
| Intangible Assets | $417.3M | 7.1% |
| Other Assets | $2.41B | 41.1% |
Liabilities Breakdown
Total Liabilities: $1.74B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $492.5M | 28.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.25B | 71.7% |